Education
About Us
Working with TipRanks
Follow Us
SIXS - ETF AI Analysis
Top Page
ETC 6 Meridian Small Cap Equity ETF (SIXS)
Rating:70Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, like HCI Group and Protagonist Therapeutics, have delivered strong year-to-date gains, supporting the ETF's overall performance.
Sector Diversification
The ETF is spread across 11 sectors, including Financials, Health Care, and Consumer Defensive, reducing reliance on any single industry.
Reasonable Expense Ratio
The fund's expense ratio is competitive for a small-cap equity ETF, helping investors keep more of their returns.
Negative Factors
High Geographic Concentration
The ETF is almost entirely focused on U.S. companies, leaving it vulnerable to domestic economic risks.
Mixed Holdings Performance
While some top holdings have performed well, others like Cal-Maine Foods have lagged, which could weigh on future returns.
Small Asset Base
With relatively low assets under management, the ETF may face liquidity challenges compared to larger funds.
SIXS vs. SPDR S&P 500 ETF (SPY)
AUM105.83M
RegionNorth America
Expense Ratio0.52%
Beta0.67
IssuerMeridian
Inception DateMay 11, 2020
Dividend Yield1.58%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume2,794
30 Day Avg. Volume3,312
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
59.70Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering84
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SIXS Summary
The ETC 6 Meridian Small Cap Equity ETF (SIXS) focuses on small-cap companies, which are typically valued between $300 million and $2 billion. These businesses often operate in emerging industries or act as disruptors in traditional sectors, offering exciting growth potential. SIXS includes a diverse mix of companies, such as HCI Group and EZCORP, and covers industries like healthcare, financials, and technology. Investors might consider this ETF for its potential to deliver higher returns over time and to diversify their portfolios with smaller, innovative companies. However, small-cap stocks can be more volatile than larger companies, meaning their prices may fluctuate more dramatically.
How much will it cost me?The ETC 6 Meridian Small Cap Equity ETF (SIXS) has an expense ratio of 0.52%, which means you’ll pay $5.20 per year for every $1,000 invested. This is higher than average because the fund is actively managed, focusing on small-cap stocks that require more research and oversight compared to passively managed funds tracking broad indexes.
What would affect this ETF?The ETC 6 Meridian Small Cap Equity ETF (SIXS) could benefit from economic growth and innovation in the U.S., as small-cap companies often thrive in expanding markets and emerging industries. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller firms, and economic slowdowns, which tend to impact small-cap stocks more significantly due to their higher volatility. Additionally, sector-specific risks, such as regulatory changes in health care or financial sectors, could influence performance.
SIXS Top 10 Holdings
The ETC 6 Meridian Small Cap Equity ETF (SIXS) leans heavily into U.S. small-cap stocks, with a notable tilt toward financials and healthcare. Protagonist Therapeutics is a standout, rising on strong technical momentum, while Pediatrix Medical Group adds steady gains thanks to solid earnings performance. On the flip side, Cal-Maine Foods is lagging, weighed down by declining recent performance. The fund’s broad sector exposure helps balance risks, but its concentration in smaller, agile companies means volatility could be a constant companion for investors seeking growth potential.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| International Seaways | 2.77% | $2.93M | $2.66B | 35.89% | 76 Outperform | |
| EZCORP | 2.50% | $2.64M | $1.13B | 43.78% | 75 Outperform | |
| Innoviva | 2.38% | $2.52M | $1.62B | 14.02% | 61 Neutral | |
| HCI Group | 2.34% | $2.48M | $2.28B | 50.46% | 73 Outperform | |
| Enact Holdings | 2.33% | $2.47M | $5.64B | 10.89% | 82 Outperform | |
| Cal-Maine Foods | 1.76% | $1.86M | $4.07B | -13.22% | 84 Outperform | |
| Protagonist Therapeutics | 1.72% | $1.81M | $5.62B | 100.45% | 70 Neutral | |
| Pediatrix Medical Group | 1.63% | $1.73M | $2.12B | 66.89% | 76 Outperform | |
| Teradata | 1.57% | $1.66M | $2.66B | -11.51% | 67 Neutral | |
| Clearway Energy | 1.47% | $1.56M | $7.29B | 22.58% | 70 Neutral |
SIXS Technical Analysis
Positive
―
Price Trends
49.13
Positive
48.93
Positive
47.38
Positive
Market Momentum
0.12
Negative
63.24
Neutral
86.11
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SIXS, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 48.90, equal to the 50-day MA of 49.13, and equal to the 200-day MA of 47.38, indicating a bullish trend. The MACD of 0.12 indicates Negative momentum. The RSI at 63.24 is Neutral, neither overbought nor oversold. The STOCH value of 86.11 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SIXS.
SIXS Peer Comparison
Comparison Results
Performance Comparison
SIXS
ETC 6 Meridian Small Cap Equity ETF
50.28
-1.16
-2.26%
SEIM
SEI Enhanced U.S. Large Cap Momentum Factor ETF
―
―
―
OSCV
Opus Small Cap Value ETF
―
―
―
SEIS
SEI Select Small Cap ETF
―
―
―
JSML
Janus Henderson Small Cap Growth Alpha ETF
―
―
―
SCDV
Bahl & Gaynor Small Cap Dividend ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents